Nuveen Asset Management’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-57,785
| Closed | -$644K | – | 3372 |
|
|
2022
Q1 | $644K | Sell |
57,785
-2,161,240
| -97% | -$24.1M | ﹤0.01% | 2942 |
|
|
2021
Q4 | $29M | Buy |
2,219,025
+254,130
| +13% | +$3.32M | 0.01% | 1003 |
|
|
2021
Q3 | $25.6M | Buy |
1,964,895
+89,385
| +5% | +$1.16M | 0.01% | 1100 |
|
|
2021
Q2 | $27.6M | Buy |
1,875,510
+68,610
| +4% | +$1.01M | 0.01% | 1127 |
|
|
2021
Q1 | $22.2M | Buy |
1,806,900
+4,160
| +0.2% | +$51.1K | 0.01% | 1240 |
|
|
2020
Q4 | $25.7M | Buy |
1,802,740
+438,115
| +32% | +$6.25M | 0.01% | 1083 |
|
|
2020
Q3 | $19M | Buy |
1,364,625
+666,660
| +96% | +$9.27M | 0.01% | 1093 |
|
|
2020
Q2 | $7.4M | Buy |
697,965
+190,720
| +38% | +$2.02M | ﹤0.01% | 1685 |
|
|
2020
Q1 | $4.09M | Sell |
507,245
-126,935
| -20% | -$1.02M | ﹤0.01% | 1834 |
|
|
2019
Q4 | $5.15M | Sell |
634,180
-7,420
| -1% | -$60.2K | ﹤0.01% | 1981 |
|
|
2019
Q3 | $4.86M | Buy |
641,600
+9,905
| +2% | +$75.1K | ﹤0.01% | 1970 |
|
|
2019
Q2 | $4.73M | Sell |
631,695
-3,790
| -0.6% | -$28.4K | ﹤0.01% | 2026 |
|
|
2019
Q1 | $5.15M | Buy |
+635,485
| New | +$5.15M | 0.03% | 505 |
|
|
2014
Q3 | – | Sell |
-395,635
| Closed | -$3.41M | – | 1546 |
|
|
2014
Q2 | $3.41M | Buy |
395,635
+187,740
| +90% | +$1.62M | 0.02% | 607 |
|
|
2014
Q1 | $1.83M | Buy |
+207,895
| New | +$1.83M | 0.01% | 803 |
|